NON-PROLIFERATIVE RETINOPATHY

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting NON-PROLIFERATIVE RETINOPATHY:

# Drug Count
0 METFORMIN 8
1 METFORMIN ER 500 MG 6
2 METFORMIN ER 750 MG 6
3 ROSUVASTATIN 4
4 INSULIN GLARGINE 3
5 INSULIN HUMAN 3
6 TIRZEPATIDE 3
7 AMLODIPINE BESYLATE 2
8 ARIPIPRAZOLE 2
9 DAPAGLIFLOZIN 2
See all common drugs associated with NON-PROLIFERATIVE RETINOPATHY

NON-PROLIFERATIVE RETINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INSULIN DEGLUDEC AND LIRAGLUTIDE 1 0.0006
1 UREA 1 0.0005
2 INSULIN ASPART INJECTION 1 0.0004
3 INSULIN GLARGINE AND LIXISENATIDE 1 0.0003
4 GLUCAGON 1 0.0002
5 CLINDAMYCIN PHOSPHATE 1 0.0002
6 VALPROATE SODIUM 2 0.0001
7 INSULIN GLARGINE-YFGN 2 0.0001
8 CLOTRIMAZOLE TOPICAL 1 0.0001
9 CLOTRIMAZOLE 1 0.0001
See all drugs enriched for association with NON-PROLIFERATIVE RETINOPATHY